Detalhe da pesquisa
1.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet Oncol
; 17(1): 57-66, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26655425
2.
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Br J Haematol
; 168(6): 824-34, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25546611
3.
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet
; 381(9873): 1203-10, 2013 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-23433739
4.
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
Int J Cancer
; 126(4): 909-18, 2010 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19728336
5.
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Cancer Immun
; 7: 16, 2007 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-17944437
6.
Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma.
Leuk Lymphoma
; 48(2): 349-56, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17325896
7.
Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.
Cancer Res
; 65(9): 3937-41, 2005 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15867394
8.
Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Haematologica
; 91(5): 596-604, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16670065
9.
Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways.
Cell Signal
; 17(5): 581-95, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15683733
10.
In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
Cancer Res
; 62(6): 1768-75, 2002 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-11912153
11.
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update.
Leuk Lymphoma
; 57(4): 766-82, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26592922
12.
Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
Exp Hematol
; 32(7): 649-56, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15246161
13.
In vitro studies with bendamustine: enhanced activity in combination with rituximab.
Semin Oncol
; 29(4 Suppl 13): 12-4, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12170426
14.
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Biochem Pharmacol
; 68(1): 85-93, 2004 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15183120
15.
Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
Biochem Pharmacol
; 66(5): 711-24, 2003 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12948851
16.
Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts.
Leuk Res
; 26(4): 383-9, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-11839382
17.
In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins.
Hematol J
; 5(6): 513-8, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15570294
18.
Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype.
Leuk Lymphoma
; 43(12): 2363-8, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12613525
19.
Expression and function of prostate-apoptosis-response-gene-4 in lymphatic cells.
Leuk Lymphoma
; 43(9): 1737-41, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12685825
20.
Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus.
Leuk Lymphoma
; 45(7): 1429-36, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15359644